UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, DC 20549

                                 FORM 10-Q


(Mark One)

[X]   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934
                   For the quarterly period ended March 31, 2001

[   ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


                        Commission File Number:  0-27524

-------------------------------------------------------------------------------
                     DYNAMOTIVE TECHNOLOGIES CORPORATION
            (Exact name of Registrant as specified in its charter)
-----------------------------------------------------------------------------

            British Columbia                                    N/A
--------------------------------------            ---------------------------
     (State or other jurisdiction of                     (I.R.S. Employer
      incorporation or organization)                    Identification No.)

                       Suite 105 - 1700 West 75th Avenue
                    ---------------------------------------
                           Vancouver, B.C. V6P 6G2
                    (Address of principal executive offices)

                                 (604) 267-6000
                           ----------------------------
                           (Issuer's telephone number)



Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No []


State the number of shares outstanding of each of the issuer's classes of
Common Stock, as of the latest practicable date:

         Class                               Outstanding at May 4, 2001
------------------------------------------------------------------------------
         Common Stock, no par value                   36,943,926




PART I  FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

      The following financial statements have been prepared in accordance with
accounting principles generally accepted in Canada.  While adhering to these
Canadian accounting principles results in financial statements disclosing an
information content substantially similar to financial statements that comply
with United States generally accepted accounting principles, there are material
variations in the two country's accounting principles, practices and methods
used. Reference should be made to the notes that accompany the Company's
financial statements as well as to Note 15 of the Company's annual report on
Form 10-K which discusses the material variations in the accountingprinciples
in Canada as compared to those followed in the United States.


<TABLE>
<CAPTION>


Interim Financial Statements                                         Page

<S>                                                                   <C>
  Consolidated Balance Sheet                                          3
  Consolidated Statement of Loss and Deficit                          4
  Consolidated Statement of Cashflow                                  5
  Notes to Interim Financial Statement                                7 - 25

</TABLE>










            CONSOLIDATED FINANCIAL STATEMENTS (in U.S. dollars)

                   DYNAMOTIVE TECHNOLOGIES CORPORATION

                             March 31, 2001



                     DynaMotive Technologies Corporation


                     CONSOLIDATED BALANCE SHEET

<TABLE>
<CAPTION>
                                              (expressed in U.S. dollars)


                                              March 31,      December 31,
                                                2001             2000
                                                  $                $
------------------------------------------------------------------------
<S>                                           <C>           <C>
ASSETS

Current
Cash and cash equivalents                       1,092,792     1,095,715
Accounts receivable                               145,392       298,676
Government grants receivable [note 5b and 8]      234,587       661,046
Inventory                                          20,998        20,528
Prepaid expenses and deposits                     185,692       136,848
------------------------------------------------------------------------
Total current assets                            1,679,461     2,212,813
------------------------------------------------------------------------
Capital assets                                  1,651,821     1,526,369
Patents                                           691,940       729,938
------------------------------------------------------------------------
                                                4,023,222     4,469,120
========================================================================

LIABILITIES AND SHAREHOLDERS' EQUITY
Current
Bank indebtedness  [note 3]                       221,983       233,520
Accounts payable and accrued liabilities          407,886       560,906
Deferred Revenue                                  122,046       103,948
------------------------------------------------------------------------
Total current liabilities                         751,915       898,374
------------------------------------------------------------------------
Commitments and contingencies [note 1, 5 and 6]
Shareholders' equity
Share capital, [note 4]                        21,881,583    21,040,882
Shares to be issued                               165,435       250,713
Contributed surplus [note 4f]                  1,829,645     1,584,997
Cumulative translation adjustment                (427,614)     (371,062)
Deficit                                       (20,177,742)  (18,934,784)
------------------------------------------------------------------------
Total shareholders' equity                      3,271,307     3,570,746
------------------------------------------------------------------------
                                                4,023,222     4,469,120
========================================================================
</TABLE>
See accompanying notes


                     DynaMotive Technologies Corporation


                     CONSOLIDATED STATEMENT OF LOSS AND DEFICIT

                     Period ended March 31      (expressed in U.S. dollars)

<TABLE>
<CAPTION>
                                              Three Months     Three Months
                                                 ended            ended
                                                March 31,        March 31,
                                                  2001             2000
                                                    $                $
---------------------------------------------------------------------------
<S>                                       <C>               <C>
REVENUE
Sales                                          97,118            266,942
---------------------------------------------------------------------------
                                               97,118            266,942
---------------------------------------------------------------------------


EXPENSES
Amortization and depreciation                  87,444             67,638
Cost of sales                                  75,780            133,208
Research and Development[note 5b and 9]        74,994            169,378
Interest expense                                6,176              3,332
Marketing                                     179,093            148,896
Office supplies, telephone and insurance       52,121             68,433
Professional fees [note 6]                    497,367            129,536
Royalties                                         --              12,826
Rent                                           83,716             32,253
General and administrative salaries
and benefits [note 6]                         293,100            679,799
---------------------------------------------------------------------------
                                            1,349,791          1,445,279
---------------------------------------------------------------------------
Loss from operations                       (1,252,673)        (1,178,337)

OTHER REVENUE AND EXPENSES
Interest income                                10,175             29,282
Loss on asset disposals                          (460)               --
---------------------------------------------------------------------------
                                               (9,715)           (29,282)
---------------------------------------------------------------------------
Loss for the Period                        (1,242,958)        (1,149,055)

Deficit, beginning of period              (18,934,784)       (14,177,911)
---------------------------------------------------------------------------
Deficit, end of period                    (20,177,742)       (15,326,966)
===========================================================================

Weighted average number of common shares
Outstanding                                34,491,242         29,626,768
---------------------------------------------------------------------------
Loss per common share                           (0.04)             (0.04)
===========================================================================
</TABLE>
See accompanying notes
                     DynaMotive Technologies Corporation



                     CONSOLIDATED STATEMENT OF CASHFLOW

                     Period ended March 31      (expressed in U.S. dollars)

<TABLE>
<CAPTION>
                                              Three Months    Three Months
                                                 ended            ended
                                                March 31,       March 31,
                                                  2001            2000
                                                    $                $
---------------------------------------------------------------------------
<S>                                        <C>               <C>
OPERATING ACTIVITIES
Loss for the period                        (1,242,958)       (1,149,055)
Add items not involving cash:
     Amortization and depreciation             87,444            67,638
     Stock based compensation                 481,594           283,668
Net change in non-cash working capital
balances related to operations [note 7]       395,508           194,033
---------------------------------------------------------------------------
Cash used in operating activities            (278,412)         (603,716)
---------------------------------------------------------------------------

FINANCING ACTIVITIES
Decrease in bank indebtedness                 (11,537)               --
Retirement of debt                                 --           (81,492)
Share subscriptions                                              82,098
Share capital issued                          518,274         4,440,550
---------------------------------------------------------------------------
Cash provided by financing activities         506,737         4,441,156
---------------------------------------------------------------------------

INVESTING ACTIVITIES
Increase in patents costs                       7,002            (3,788)
Purchase of capital assets (net of           (182,713)          (51,400)
  government grants)
Proceeds on sale of equipment                   1,015                --
---------------------------------------------------------------------------
Cash used in investing activities            (174,496)          (55,188)
---------------------------------------------------------------------------

Effect of exchange rate changes on cash       (56,552)          (12,315)
---------------------------------------------------------------------------


Increase (decrease) in cash and cash
   equivalent during the period                (2,923)        3,769,937
Cash and nning of period                    1,095,715           223,769
---------------------------------------------------------------------------
Cash end of period                          1,092,792         3,993,706
===========================================================================
</TABLE>

See accompanying notes

1. NATURE OF BUSINESS

DynaMotive Technologies Corporation ("the Company") was incorporated on April
11, 1991 under the laws of the Province of British Columbia. Since its
inception the Company has been engaged in the process of commercializing
several technologies that are in various stages of development.

The Company's primary focus is to commercialize its patented BioOil production
technology and establish this technology as the worldwide industry standard for
production of BioOil clean fuels. The Company has developed, patented, or
acquired three primary technologies: (1) BioTherm(TM), a biomass-to-energy
technology that converts low value forest waste and agricultural by-products
into liquid BioOil, which can be used as a fuel or as a raw material for the
production of various derivative products; (2) DynaPower(R), a metal cleaning
process that does not involve the use of chemicals; and (3) actuator
technologies used in both steel and aluminum welding.  To date, the Company's
principal revenues have been derived from the sales of the actuators and sales
of DynaPower(R) systems to various customer applications. The principal market
for the Company's products is in the United States.

These financial statements have been prepared on the going concern basis, which
presumes the Company will be able to realize its assets and discharge its
liabilities in the normal course of operations for the foreseeable future.

The Company incurred a net loss of $1,242,958 for the first quarter ended March
31, 2001 and as at March 31,2001 has a deficit of $20,177,742.

The ability of the Company to continue as a going concern is uncertain and is
dependent on achieving profitable operations, and continuing development of new
technologies, the outcome of which cannot be predicted at this time.
Accordingly, the Company will require, for the foreseeable future, ongoing
capital infusions in order to continue its operations, fund its research and
development activities, and ensure orderly realization of its assets at their
carrying value. The financial statements do not reflect adjustments in carrying
values and classifications of assets and liabilities that would be necessary
should the Company not be able to continue in the normal course of operations.


2. SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements have been prepared by management in
accordance with accounting principles generally accepted in Canada. A
reconciliation of amounts presented in accordance with United States accounting
principles is detailed in note 10.

The following is a summary of significant accounting policies used in the
preparation of these consolidated financial statements:



2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

PRINCIPLES OF CONSOLIDATION

These consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiaries DynaMotive Corporation, incorporated under the
laws of Rhode Island, U.S.A.; DynaMotive Europe Limited (formerly known as
DynaMotive Technologies Corporation (UK) Limited), incorporated under the laws
of the United Kingdom; DynaMotive Canada Inc., federally incorporated under the
laws of Canada; DynaPower Inc., incorporated under the law of British Columbia;
DynaMotive Puerto Rico, Inc., incorporated under the laws of Puerto Rico;
DynaMill Systems Ltd. and  DynaMotive Electrochem Corporation, incorporated
under the laws of British Columbia. DynaMill Systems Ltd., DynaMotive
Electrochem Corporation, and DynaMotive Puerto Rico, Inc. are companies with no
significant net assets or operations.


USE OF ESTIMATES

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions
that affect the amounts reported in the financial statements and accompanying
notes. Actual results could differ from these estimates.


FOREIGN CURRENCY TRANSLATION

The accounts of the Company and its consolidated subsidiaries are measured
using the Canadian dollar as the functional currency. Monetary items
denominated in foreign currencies are translated into Canadian dollars
using exchange rates in effect at the balance sheet date and non-monetary items
are translated using historical exchange rates. Exchange gains or losses
arising on the translation or settlement of foreign currency denominated
monetary items are included in the determination of net income, except for
gains or losses related to long-term monetary items which are deferred and
amortized over the life of the item.

The Company uses the U.S. dollar as the reporting currency for its consolidated
financial statements. Assets and liabilities are translated into U.S. dollars
using current exchange rates in effect at the balance sheet date and revenue
and expense accounts are translated using the average exchange rate during the
year. Gains and losses resulting from this process are recorded in
shareholders' equity as an adjustment to the cumulative translation adjustment
account.


FINANCIAL DERIVATIVES

Forward currency derivative financial instruments, such as forward contracts,
are used from time to time to manage the effects of exchange rate changes on
foreign currency exposures. Gains and losses on forward foreign exchange
contracts are not recognized until realized and are then charged to income on
a basis that corresponds with changes in the related amounts of foreign
currency expenses.


2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

REVENUE RECOGNITION

Revenue from the sale of products is recognized upon shipment of the product
to the customer. Revenue from contracts relating to implementation of the
Company's metal cleaning systems in a commercial application is recognized
on a completed contract basis, except for those which are greater than three
months in duration, for which revenue is recognized on a percentage of
completion basis where the basis of measure of performance is based on
engineering estimates of completion. Losses on contracts are recognized
when they become known.


GOVERNMENT ASSISTANCE AND INVESTMENT TAX CREDITS

Government assistance towards current expenses is included in the determination
of income for the period as a reduction of the expenses to which it relates.
Government assistance towards the acquisition of capital assets is deducted
from the cost of the related capital assets. Investment tax credits are
accounted for under the cost reduction method whereby they are netted against
the expense or capital asset to which they relate.

Investment tax credits are recorded when the Company has incurred the
qualifying expenditures and there is reasonable assurance the tax credits will
be realized.


INVENTORY

Inventory comprises of work in progress relating to the Company's products
under construction and is recorded at the lower of average cost and net
realizable value. Inventory work in progress costs include the cost of raw
materials, direct labor and overhead.


RESEARCH AND DEVELOPMENT COSTS

Research costs are expensed in the year incurred. Development costs are
expensed in the year incurred unless the Company believes the development
project meets generally accepted accounting criteria for deferral and
amortization. In evaluating these criteria the Company considers technological
feasibility to be established only when a product demonstrates it operates
under conditions which are acceptable to target customers.

If management determines that the development of products to which such costs
have been capitalized is not reasonably certain, or that costs exceed
recoverable value, such costs are charged to operations.


PRODUCT WARRANTIES

A liability for estimated warranty expense is established by a charge against
cost of goods sold. The subsequent costs incurred for warranty claims serve to
reduce the product warranty liability.
2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

PATENTS

Patents consist of the consideration paid for the patents and related legal
costs and are amortized over the lesser of the estimated useful life of the
related technology and the life of the patent commencing with commercial
production. If management determines that development of products to which
patent costs relate is not reasonably certain, or that costs exceed recoverable
value, such costs are charged to operations.

Due to the long-term nature of estimates inherent in determining future cash
flows, it is possible that the amounts or the estimated useful life of such
assets could be reduced in the future.


CAPITAL ASSETS

Capital assets are recorded at cost, net of government assistance, and
amortized using the following methods and annual rates:

<TABLE>
<CAPTION>
     <S>                        <C>
     Furniture and fixtures      20% declining balance
     Computer equipment          30% declining balance
     Computer software          100% declining balance
     Test equipment              20% declining balance
     Leasehold improvements      Straight line over the term of the lease
</TABLE>


CASH EQUIVALENTS

The Company considers all highly liquid financial instruments purchased with
an original maturity of three months or less to be cash equivalents and are
recorded at the amortized cost which approximates fair value.


FINANCIAL INSTRUMENTS

The fair values of the financial instruments approximates their carrying value
except as otherwise disclosed in the financial statements.


INCOME TAXES

The Company follows the liability method of tax allocation in accounting for
income taxes.


STOCK BASED COMPENSATION PLAN

The Company has two stock based compensation plans - a stock appreciation
rights (SAR) plan and a stock option plan for directors, employees and others,
which are described in Note 4. Under the terms of the stock option plan the
company may grant fixed options or options whose vesting is contingent on
future performance. No compensation is recognized when SAR's and fixed or
performance based stock options are granted to employees and directors.

2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

The company has a compensation arrangement with an officer of the company
whereby the officer receives a fixed number of common shares per month. The
company records compensation expense monthly based on the month-end quoted
market price of the company's stock.

In addition, the company has entered into compensation arrangements which
entitle non-employees to specific amounts which can only be settled by applying
the amounts to exercise outstanding options to purchase common shares monthly
over a period of up to twelve months. The company recognizes compensation
expense based on the fair value of the common stock issuable under the
arrangement, when related services are performed. The common shares issuable
under these arrangements are generally issued in the quarter following the
period in which they are earned.

The Company may also issue stock options, SAR's and warrants as consideration
for services rendered by non-employees. Such equity awards are recorded at
their fair value, as compensation expense when the company receives the related
services and the equity awards vest. No compensation is recognized in
connection with options and warrants awarded in connection with private
placements, since the share issue costs are net against the proceeds raised.

If shares or stock options are repurchased, the excess of the consideration
paid over the carrying value of the shares or stock options cancelled is
charged to contributed surplus or deficit.


LOSS PER COMMON SHARE

Loss per common share is based on the weighted average number of shares
outstanding for the year including escrowed shares. The effect of potential
issues of shares under share option, share purchase warrants and conversion
agreements have not been disclosed as they are antidilutive.



3. BANK INDEBTEDNESS

The Company has an authorized credit facility up to a maximum of $327,247
[$Cdn. 500,000]. As collateral for the loan, the Company has provided the
lender a General Security Agreement providing a charge on all present and
future assets. Amounts borrowed are repayable within 120 days from the date of
borrowing and as at March 31,2001 $221,983 (Cdn. $350,000) has been drawn down
on this loan.

Covenants under the credit facility include, among other things, a requirement
for the Company to obtain written consent prior to declaring dividends,
significantly changing ownership control, committing to mergers, acquisitions,
or changes in Company's principal line of business or entering other guarantees
or other contingent liabilities and assets are not to be further encumbered.

The fair market value of the loan March 31, 2001 approximates its carrying
value.




4. SHARE CAPITAL

[a]  AUTHORIZED SHARE CAPITAL AND ISSUED COMMON SHARES

<TABLE>
<CAPTION>
                                                             March 31,        December 31,
                                                               2001               2000
                                                                 $                 $
------------------------------------------------------------------------------------------
<S>                                                          <C>              <C>

Authorized
100,000,000 common shares
100,000,000 preferred shares Class A with $5.00 par value

Issued and outstanding

36,745,548 [December 31, 2000 - 35,851,060]                  $21,881,583      $21,040,882
------------------------------------------------------------------------------------------
</TABLE>


  [i]   Pursuant to a private placement on February 20, 2001, the Company
        issued 417,246 common shares for total cash proceed of $500,695.

  [ii]  During the first quarter of 2001, 27,333 common shares were issued to
        directors at $0.81 per common share in lieu of cash compensation.

  [iii] During the first quarter of 2001, 405,963 common shares were issued as
        payment for commercial services based upon reported share prices
        ranging from $0.50 to $2.00 per common share.

<TABLE>
<CAPTION>
                                                       $         Number of Shares
---------------------------------------------------------------------------------
<S>                                                 <C>             <C>

Share Capital, December 31, 2000                    21,040,882      35,851,060

Private placement issued for cash                      500,695         417,246
Shares issued from exercise of options for cash         17,579          43,946
Shares issued, directors & employees compensation       22,208          27,333
Shares issued, for commercial services                 300,219         405,963

Share Capital, March 31, 2001
    Common shares without par value                 21,881,583      36,745,548
---------------------------------------------------------------------------------
At March 31, 2001, the Company has 170,570 common shares to be issued to an
officer and non-employees for services rendered under compensation arrangements.
</TABLE>




4. SHARE CAPITAL (cont'd.)

[b]  ESCROW AGREEMENT

At December 31, 1998, 1,232,000 common shares were held in escrow to be
releasedat a rate of one share for each $0.17 of "cash flow" as defined in
the agreement, generated by the Company.

During 1999, the Board approved an amendment to the Escrow agreement's release
provisions that applied to 676,000 of the shares held in escrow. The amended
release provisions are: 1/3 of the common shares in escrow will be released
upon the Company achieving a capitalized stock value of $30 million for a
consistent twenty day trading period; 1/3 of the common shares in escrow will
be released upon the Company achieving a capitalized stock value of $50 million
for a consistent twenty day trading period; 1/3 of the common shares in escrow
will be released upon the Company achieving a capitalized stock value of $100
million for a consistent twenty day trading period.

During the first quarter of 2001 no common shares were released from
escrow and at March 31, 2001  781,334 common shares are held in escrow.

[c]  STOCK OPTIONS

At March 31, 2001 the following stock options to Directors, employees and
others were outstanding:

<TABLE>
<CAPTION>
   No. of common      Exercise Price
  shares issuable            $           Date of expiry
------------------------------------------------------------------------------
<S>                        <C>           <C>
        655,236            0.40          April 30, 2001 - December 10, 2004
        100,000            0.50          January 31, 2005
        620,100            0.75          January 31, 2002 - January 31, 2004
        883,500            1.00          January 31, 2002 - February 28, 2005
      2,560,000            1.50          April 30, 2001 - January 31, 2006
         20,000            1.95          June 14, 2005
         41,722            2.00          July 31, 2001 - December 19, 2002
          6,000            2.75          December 1, 2002
         12,000            3.13          November 15, 2001
          3,985            4.00          October 31, 2002
         50,000            5.50          November 12, 2001
------------------------------------------------------------------------------
      4,952,543
==============================================================================
</TABLE>

From time to time, the Company has provided incentives in the form of share
purchase options to the Company's directors, officers and employees. The
Company has reserved 5,511,832 (15%) of common shares for issuance upon the
exercise of stock options of which at March 31, 2001 559,289 are available
to be granted. The exercise price and the vesting terms of the options are
determined by the Compensation Committee. The exercise price will generally
be at least equal to the market price of the common shares at the date of
the grant and the term may not exceed five years from the date of the grant.
Stock options granted are also subject to certain vesting provisions
as determined by the Compensation Committee.

4. SHARE CAPITAL (cont'd.)

Stock option transactions for the respective periods and the number of stock
options outstanding are summarized as follows:

<TABLE>
<CAPTION>
                                       No. of Common       Weighted Average
                                      SHARES ISSUABLE       EXERCISE PRICE
-------------------------------------------------------------------------------
<S>                                   <C>                       <C>
BALANCE, DECEMBER 31, 1997            1,547,385                 2.58
-------------------------------------------------------------------------------
Options granted                         872,635                 0.46
Options cancelled                      (478,566)                2.48
Options exercised                       (96,943)                0.75
-------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 1998            1,844,511                 0.73
-------------------------------------------------------------------------------
Options granted                       1,070,863                 1.11
Options cancelled                      (262,634)                0.97
Options exercised                      (242,601)                0.46
-------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 1999            2,410,139                 0.90
-------------------------------------------------------------------------------
Options granted                       3,885,500                 1.17
Options cancelled                      (265,278)                1.63
Options expired                         (63,600)                2.19
Options exercised                      (737,119)                0.54
-------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 2000            5,229,642                 1.14
-------------------------------------------------------------------------------
Options granted                         128,000                 1.32
Options cancelled                            --                   --
Options expired                          15,000                 2.00
Options exercised                      (390,099)                1.45
-------------------------------------------------------------------------------
BALANCE, MARCH 31, 2001               4,982,543                 1.12
-------------------------------------------------------------------------------
</TABLE>

During 2000, the Company repriced 234,278 options issued to non-employees from
original exercise prices ranging from $1.50 to $2.00 to a new exercise price
of $0.75, the then market price of the shares.

On December 14, 1998, the Company repriced 318,000 options issued to Directors
from an original exercise price of $2.00 to $0.40. On December 10, 1999 these
same options were repriced again from $0.40 to $1.00.

Included in the options granted in 2001, were 48,000 options to a non-employee
for services rendered.  The valuation of this stock based compensation is to be
 recorded at fair value when related services are performed.



4. SHARE CAPITAL (cont'd.)

[d]  COMMON SHARE PURCHASE WARRANTS

At March 31, 2001 common share purchase warrants outstanding were as follows

<TABLE>
<CAPTION>
                             Number of Common     Exercise     Expiration
                              Shares Issuable      Price         Date
---------------------------------------------------------------------------------------------
<S>                            <C>                 <C>         <C>
   Series F Warrants           2,075,000           $1.50       March 5, 2005
   Series G Warrants             300,000           $2.50       March 01, 2003
   Series H Warrants              15,000           $1.75       May 31, 2002
   Series I Warrants              15,000           $2.50       May 31, 2002
   Series J Warrants           1,005,000           $2.00       July 31, 2002 - July 31, 2003
   Series K Warrants              75,000           $1.50       July 31, 2003
---------------------------------------------------------------------------------------------
</TABLE>


(1) 2,000,000 of the Series F warrants were issued as an integral part of a
    private placement. These warrants vested upon successful completion of
    the private placement.

    75,000 of the Series F warrants were issued to an employee of the company
    for past services.

(2) The Series G warrants were issued as a placement fee for a private
    placement. These warrants vested upon successful completion of the private
    placement.

(3) The Series H, I, J, and K warrants have been issued for services. Of
    these warrants, 75,000 have been issued to an employee of the company for
    past services. The remaining warrants have been issued to non-employees.
    The warrants remaining have the following vesting terms: 675,000 warrants
    vest monthly based on the consulting agreement term; 120,000 warrants vest
    upon completion of performance criteria; and, 315,000 warrants vested
    immediately upon grant.


As at March 31, 2001, 393,333 warrants are unvested. Compensation for the first
quarter in respect of the vested warrants has been recorded at a fair value of
$201,243.

[e]  STOCK APPRECIATION RIGHTS

During 1998, the company established a stock appreciation rights plan whereby
the participants will be entitled to require the company to redeem the stock
appreciation rights ("SARs") for an amount equal to the excess of the market
value of the underlying common shares over the initial value of the SAR at the
date of grant.


4. SHARE CAPITAL (cont'd.)

The SARs vest as the Company achieves stock values as defined in the agreement:
1/3 of the SAR's issued may be redeemed upon the Company achieving a
capitalized stock value of $30 million for a consistent twenty day trading
period; 1/3 of the SAR's issued may be redeemed upon the Company achieving a
capitalized stock value of $50 million for a consistent twenty day trading
period; 1/3 of the SAR's issued may be redeemed upon the Company achieving a
capitalized stock value of $100 million for a consistent twenty day trading
period.

The Company also has the right to redeem the SARs at its option under certain
circumstances. The number of SARs that can be granted under the plan until
December 31, 2008 cannot exceed 2,500,000.

Stock appreciation rights transactions and the number of stock appreciation
rights outstanding at March 31, 2001 are summarized as follows:


<TABLE>
<CAPTION>
                                                                      No. of
                                                                  SAR's Issued
------------------------------------------------------------------------------
<S>                                                                 <C>
Balance, December 31, 1999 and 1998                                 1,747,500
SAR's redeemed                                                        (11,667)
------------------------------------------------------------------------------
Balance, December 31, 2000                                          1,735,833
------------------------------------------------------------------------------
Balance, March  31, 2001                                            1,735,833
------------------------------------------------------------------------------
</TABLE>

At March 31, 2001, the following stock appreciation rights all of which were
issued to employees, were outstanding:

<TABLE>
<CAPTION>
           SAR's        Initial Value	                Expiration Date
------------------------------------------------------------------------------
<S>                       <C>                      <C>
       1,253,333          $0.400	                   January 28, 2004
         200,000          $0.625	                        May 1, 2004
         207,500          $1.000	                        May 1, 2004
          75,000          $1.000	                      March 8, 2004
------------------------------------------------------------------------------
       1,735,833
------------------------------------------------------------------------------
</TABLE>



4. SHARE CAPITAL (cont'd.)

[f]  CONTRIBUTED SURPLUS

During 1994, the Company entered into an escrow agreement with certain
shareholders, Directors and employees, whereby the Company issued 2,512,720
common shares for cash consideration of $22,300.  During 1995, the Company
repurchased for cash 1,280,720 of these common shares at their original issue
price of $11,366. The excess of the weighted average cost of the 1,280,720
common shares repurchased and cancelled over the purchase price, amounting to
$409,030 ($Cdn. 560,315), has been credited to contributed surplus.

Contributed surplus also includes the fair value of stock options and warrants
issued to non-employees for services rendered.


5. COMMITMENTS AND CONTINGENCIES

Commitments

[a]  Pursuant to an agreement to purchase certain patents, the Company is
committed to pay a royalty of $7,100 on each sale of a unit of related product
to a maximum of $106,500. No sales have occurred to March 31, 2001 on which the
Company owes such royalty.

[b]  During the year ended December 31, 1997, the Company entered into a
contribution agreement with Industry Canada-Technology Partnerships Canada
whereby the Company is entitled to receive a maximum of approximately $6.1
million or 37% of eligible expenditures, as defined in the agreement. In the
event that commercial viability is achieved, then the assistance is repayable,
denominated in Canadian dollars, commencing February 15, 2002 based on
royalties from sales of specified products after December 31, 2001 resulting
from the project to a maximum of $11 million. During the first quarter of 2001,
$211,578 was claimed and is included in government grants receivable [see
note 9]. The company has yet to achieve commercial viability.

[c]  The Company has available a maximum aggregate forward exchange contract
facility of up to $750,000 U.S. dollars or the equivalent thereof in other
approved currencies. The daily settlement limit is $250,000. No such
instruments were outstanding at March 31, 2001.

[d]  The Company has the following future minimum lease commitments for
premises and equipment expiring through 2005:

<TABLE>
<CAPTION>
                                                                        $
------------------------------------------------------------------------------
<S>                                                                   <C>
2001                                                                  171,750
2002                                                                  219,000
2003                                                                  214,000
2004                                                                  124,000
2005                                                                  119,000
------------------------------------------------------------------------------
                                                                      905,000
------------------------------------------------------------------------------
</TABLE>


5. COMMITMENTS AND CONTINGENCIES (Cont'd.)

Contingencies

In the ordinary course of business activities, the Company may be contingently
liable for litigation and claims with customers, suppliers and former
employees. Management believes that adequate provisions have been recorded in
the accounts where required. Although it is not possible to estimate the
extent of potential costs and losses, if any, management believes that the
ultimate resolution of such contingencies will not have a material adverse
effect on the consolidated financial position of the Company.

[a]  In 1996 the Company was named as a co-defendant in a legal action for
unspecified damages for alleged interference with the rights to a
disintegration technology held by a subsidiary of the Company. The outcome of
the action is not determinable at this time and the amount of any liability,
if any, cannot be reasonably estimated. Accordingly, no provision for loss has
been made in these consolidated financial statements.

[b]  The Company is a party to a legal proceeding filed by HPG Research Ltd
for an alleged breach of a royalty agreement and a potential claim of a
Certain percentage of DynaPower sales. The parties have agreed to proceed with
arbitration, as provided for under the agreement.


6. RELATED PARTY TRANSACTIONS

In addition to the transactions described in Note 4, the Company had the
following transactions with related parties:

[a]  Consulting fees and salaries of $117,168 for the first quarter have
been paid to Directors (or companies controlled by Directors) of the Company.

[b]  The Company has entered into:

  [i]   a royalty agreement, pursuant to an agreement to purchase certain
        patents for an unlimited term with a company controlled by a previous
        Director of the Company, based on 4% of the gross receipts from unit
        sales. No sales have occurred to date.

  [ii]  a royalty agreement during 1993, pursuant to the use of certain
        proprietary information, with a company controlled by a former officer
        of the Company to pay the greater of $7,100 in 1996 and increasing by
        $3,600 each subsequent anniversary or 10% of the net proceeds of the
        sale of the components, for each anniversary date, developed from
        certain proprietary information for an unlimited term. If the Company
        fails to make a payment as required, it will forfeit all rights
        relating to the agreement including any patents or sub-licenses to
        third parties. No royalty expense has been recorded for 2001.

[iii]   During 2000, the Company entered into a 24 month consulting and
        research agreement, expiring February 9, 2002, with a company
        controlled by a board member of the Company. The contract fees are
        $10,000 ($15,000 Cdn) per month. The agreement is extendable annually
        by mutual agreement. Included in research and development expenses are
        fees of $30,000 to this related party.


7. NET CHANGE IN NON-CASH WORKING CAPITAL BALANCES

<TABLE>
<CAPTION>
                                          Three Months          Twelve Months
                                              ended                 ended
                                          March 31, 2001      December 31, 2000
                                                $                     $
-------------------------------------------------------------------------------
<S>                                         <C>                   <C>
Accounts and government
grants receivable                            579,743              (140,591)
Work in progress/Inventory                      (470)               17,422
Prepaid expenses and deposits                (48,845)               (7,318)
Accounts payable and accrued liabilities    (153,020)               46,485
Deferred Revenue                              18,098              (161,176)
-------------------------------------------------------------------------------
                                             395,508              (245,178)
===============================================================================
Supplementary information
-------------------------------------------------------------------------------
Interest paid                                  6,176                26,523
===============================================================================
</TABLE>



8. MAJOR CUSTOMERS

[a]The Company sells to multiple customers. The majority of sales for the
period ended March 31, 2001 were derived from 3 customers each representing
61%, 20% and 15%, respectively of consolidated sales. The majority of sales
for the year ended March 31, 2000 were derived from 2 customers each
representing 58% and 40% respectively of consolidated sales.  As at March 31,
2001 the aggregate accounts receivable balances relating to these customers was
$44,500.

[b]During the year ended December 31, 1997 the Company entered into an
exclusive royalty licensing agreement with a major customer which provides
that customer the rights to the use of certain technology developed by the
Company for the production of actuators for welding applications. The licensing
agreement provides for a five year non-competition period specifically related
to stud welding.  No licensing revenue have been recognized for the period
ended March 31, 2001



9. GOVERNMENT ASSISTANCE

Government assistance in the amount of $211,578 has been recorded as a
reduction of expenditures for the period.

In addition to government assistance disclosed in note 5 [b], during 2000, the
Company entered into a contribution agreement with Natural Resources Canada
whereby the Company is entitled to receive a maximum of $163,623 (Cdn -
$250,000) as defined in the agreement. The contribution is non-repayable.
In 2000, $163,623 was claimed of which $23,009 is included in government grants
receivable as at March 31, 2001.

10. SEGMENTED INFORMATION

The Company has five reportable segments. The segments are DynaPower(R),
Actuators, BioTherm(TM), Corporate, and Other. DynaPower(R) is a process for
cleaning metal without the use of chemicals. The actuator technology is used
in both steel and aluminum welding. BioTherm(TM) is a biomass-to-energy
technology that converts low value forest waste and agricultural by-products
into BioOil, while Corporate consists of interest. Other includes a pulverizing
technology which disintegrates a variety of solid materials and organic waste
into a form suitable for the production of BioOil.

   The accounting policies of the segments are the same as those described in
the summary of significant accounting policies. The Company evaluates
performance based on many factors, including net income or loss.

   The Company's reportable business segments are strategic business units that
offer different products and services. They are managed separately because each
business requires different technology and marketing strategies.


9. SEGMENTED INFORMATION (cont'd.)

<TABLE>
<CAPTION>
                                             March                 March
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                       <C>                   <C>
REVENUE
Actuator                                        --                     --
DynaPower(R)                                  96,529               266,942
BioTherm(TM)                                    --                     --
Other                                           --                     --
Corporate                                        589                   --
------------------------------------------------------------------------------
                                              97,118               266,942
------------------------------------------------------------------------------
LOSS FOR THE PERIOD
Actuator                                      (7,586)               (4,438)
DynaPower(R)                                 (96,677)               (1,766)
BioTherm(TM)                                (204,907)             (380,043)
Other                                         (3,907)               (4,186)
Corporate                                   (929,881)             (758,622)
------------------------------------------------------------------------------
                                          (1,242,958)           (1,149,055)
------------------------------------------------------------------------------
</TABLE>


10. SEGMENTED INFORMATION

<TABLE>
<CAPTION>
                                             March                 December
                                              2001                   2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                          <C>                 <C>
CAPITAL EXPENDITURES, INCLUDING PATENTS
(NET OF GRANT & DISPOSAL)
Actuator                                         --                    --
DynaPower(R)                                   8,924               111,557
BioTherm(TM)                                 130,067             1,110,863
Other                                         14,367                 3,984
Corporate                                     21,338               224,463
------------------------------------------------------------------------------
                                             174,696             1,450,867
------------------------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>
                                             March                 March
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                           <C>                   <C>
AMORTIZATION
Actuator                                       7,586                 4,438
DynaPower(R)                                  29,264                23,406
BioTherm(TM)                                  29,505                27,428
Other                                          3,553                 4,186
Corporate                                     17,536                 8,180
------------------------------------------------------------------------------
                                              87,444                67,638
------------------------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>
                                             March                December
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                        <C>                  <C>
TOTAL ASSETS
Actuator                                      56,151	               63,737
DynaPower(R)                                 435,792	              476,462
BioTherm(TM)                               1,530,239            1,429,496
Other                                         86,127	               75,295
Corporate                                  1,914,913            2,424,130
------------------------------------------------------------------------------
                                           4,023,222            4,469,120
------------------------------------------------------------------------------
</TABLE>


10. SEGMENTED INFORMATION

Geographic Information

The Company holds substantially all of its capital assets in Canada and
revenues from external customers by customer location is as follows:


<TABLE>
<CAPTION>
                                             March                 March
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                           <C>                  <C>
Revenue
United States                                 14,818               154,934
Italy                                          3,420                 5,157
Canada                                        59,015               106,851
France                                        19,505                   --
Other                                            360                   --
------------------------------------------------------------------------------
                                              97,118               266,942
------------------------------------------------------------------------------
</TABLE>



11.  RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES

The Company prepares the consolidated financial statements in accordance with
accounting principles generally accepted in Canada ("Canadian GAAP"), which
conform in all material respects to those in the United States ("U.S. GAAP"),
except as follows:

[i]   Under U.S. GAAP, basic earnings per share excludes any dilutive effects
      of options, warrants, convertible securities and shares in escrow.
      Diluted earnings per share are calculated in accordance with the
      treasury stock method and are based on the weighted average number of
      common shares and dilutive common share equivalents outstanding.

[ii]  Under U.S. GAAP, the excess, if any, between the fair value of the shares
      in escrow and the nominal amount paid, will be recorded as compensation
      expense upon release from escrow.

[iii] Under U.S. GAAP, patent costs are amortized over the life of the patent
      commencing with the date the patent is granted.

[iv]  Under U.S. GAAP, stock based compensation to non-employees is recorded
      at the fair market value of the shares issued.

[v]   For reconciliation purposes to U.S. GAAP, the Company has elected to
      follow Accounting  Principles Board Opinion No. 25 "Accounting for Stock
      Issued to Employees" (APB 25) in accounting for its employee stock
      options. The exercise price of 70,000 (1999 - 33,196; 1998 - 316,969)
      fixed employee stock options granted in 2000 were less than the market
      price of the underlying stock on the date of the grant.   The exercise
      price of fixed employee stock options granted in 2001 were greater than
      the market price of the underlying stock on the date of the grant.

11.  RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES

[vi]  For purposes of reconciliation to U.S. GAAP, the re-pricing of options
      can give rise to additional compensation expense. In fiscal 2000, no
      compensation expense resulted from the re-pricing of options based on the
      transition provision of FIN44, commencing July 1, 2000. Options repriced
      after December 15, 1998 are subject to variable plan accounting under
      U.S. GAAP. In the pro forma information on net income and earnings per
      share, pursuant to the provisions of Statement of Financial Accounting
      Standards No. 123 "Accounting for stock based compensation" ("SFAS 123"),
      additional compensation expense in respect of the re-pricing of the
      options has been reflected.

[vii] For purposes of reconciliation to U.S. GAAP, the stock appreciation
      rights ("SARs") and performance based stock options are accounted for as
      a variable compensation plan under APB 25. Compensation relating to
      variable plans is recorded in the reconciliation when it becomes probable
      that the award will be earned.

[viii]For purposes of reconciliation to U.S. GAAP, the Company presents the
      disclosure requirements of Financial Accounting Standard No. 130
      ("SFAS 130") in these consolidated financial statements. SFAS 130
      requires the presentation of comprehensive income and its components.
      Comprehensive income includes all changes in equity during a period
      except shareholder transactions. Other accumulated comprehensive income
      comprises only the cumulative translation adjustment.

If accounting principles generally accepted in the United States were
followed, the significant variations on the consolidated statements of loss
and comprehensive loss would be as summarized in the table below.

<TABLE>
<CAPTION>
                                                 Three Months    Three Months
                                                     ended           ended
                                                    March 31,       March 31,
                                                      2001            2000
                                                        $               $
------------------------------------------------------------------------------
<S>                                               <C>             <C>
Loss for the period, Canadian GAAP                 1,242,959       1,149,055
Adjustment for patent cost amortization                1,785             988
Adjustment for stock-based compensation                6,803         129,802
Adjustment for variable accounting expenses               --         198,750
------------------------------------------------------------------------------
Loss for the year, as adjusted                     1,251,546       1,478,595
------------------------------------------------------------------------------

Unrealized losses on foreign currency translation     56,552          17,412
------------------------------------------------------------------------------
Comprehensive loss for the year, U.S. GAAP         1,308,097       1,496,007
------------------------------------------------------------------------------
Weighted average number of common shares
      Outstanding                                 34,491,242      29,626,768
------------------------------------------------------------------------------

Loss per common share, U.S. GAAP                       (0.04)          (0.05)
==============================================================================
</TABLE>

10.  RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (cont'd.)

Consolidated balance sheet items which vary significantly under accounting
principles generally accepted in the United States would be as follows:


<TABLE>
<CAPTION>
                                           March 31,            December 31,
                                             2000                   2000
                                               $                      $
------------------------------------------------------------------------------
<S>                                    <C>                     <C>
Patents                                    649,772                 651,558
==============================================================================
Total assets                             4,021,436               4,390,740
==============================================================================

Share capital                           24,335,292              23,409,409
Share deposit                              165,435                 250,713
Contributed surplus                      1,829,645               1,584,997
Cumulative translation adjustment         (427,614)               (371,062)
Deficit                                (22,633,237)            (21,381,691)
------------------------------------------------------------------------------
Shareholders' equity                     3,269,521                3,492,366
==============================================================================
</TABLE>


The weighted-average fair value of options granted in 2001 where the stock
price is equal to the exercise price of the options, greater than the exercise
price of the options and less than the exercise of the options was $0.00,
$0.00, and $0.67 respectively.

The Black Scholes options valuation model was developed for use in estimating
the fair value of traded options which have no vesting restrictions and are
fully transferable. In addition, option valuation models require the input of
highly subjective assumptions including the expected stock price volatility.
Because the Company's employee stock options have characteristics
significantly different from those of traded options, and because changes in
the subjective input assumptions can materially affect the fair value
estimate, in management's opinion, the existing models do not necessarily
provide a reliable single measure of the fair value of its employee stock
options.

Pro forma information regarding net income and earnings per share as required
by Statement of Financial Accounting Standard No. 123 "Accounting for stock
based compensation" ("SFAS 123"), is estimated at the date of grant using a
Black Scholes pricing model with the following assumptions: Risk free interest
rate for 2001 of 5.0%, dividend yields of 0%; volatility factors of the
expected market price of the Company's common stock of 1.303 and a weighted
average expected life of the option of 5 years.


10.  RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (cont'd.)

Supplemental disclosure of pro forma loss and loss per share:


<TABLE>
<CAPTION>
                                                                March 31, 2000
------------------------------------------------------------------------------
<S>                                                              <C>
Pro forma loss                                                   1,274,247
Pro forma loss per share                                             (0.04)
==============================================================================
</TABLE>



12. SUBSEQUENT EVENTS

In April 2000, the Company acquired 75% of Border Biofuels Limited (BBL),a UK
Green Power project development company. Through the acquisition of BBL, the
Company has accessed 15 year power purchase contracts in the UK for the
production of 60 MW of electricity. Projects are to be fuelled by BioOil. The
contracts provide an option for, but not the obligation to provide power.



13. COMPARATIVE FIGURES

Certain comparative figures have been reclassified in order to conform with
the presentation adopted in the current year.



ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
            FINANCIAL CONDITION AND RESULTS OF OPERATIONS
INTRODUCTION

     DynaMotive Technologies Corporation is an energy systems company that is
a world leader in the development of technology to produce competitively
priced fuels from renewable and non-depleting biomass. DynaMotive's liquid
fuel, known as BioOil, presents significant market opportunities that the
Company intends to exploit commercially as a clean fuel to replace natural
gas, diesel and other fossil fuels to produce power and heat in industrial
boilers, gas turbines and diesel engines. The Company and its partners are
also engaged in research and development on a range of derivative products
that, if successful, could further enhance the market and value for BioOil as
an alternative fuel and product source.

     DynaMotive Technologies Corporation was incorporated on April 11, 1991
in the Province of British Columbia, Canada, by registration of its Memorandum
of Articles, pursuant to the Company Act of British Columbia under the name of
DynaMotive Canada Corporation. On October 31, 1995, the shareholders approved a
change of name to the Company's current name. As of March 31, 2001, the Company
had seven wholly-owned subsidiaries: DynaMotive Corporation (incorporated in
the State of Rhode Island in 1990 and holding some of the Company's patents),
DynaMotive ElectroChem Corporation (incorporated in the Province of British
Columbia in 1993), DynaMotive Europe Limited (incorporated in the United
Kingdom in 1996 under the name of DynaMotive Technologies (UK) Ltd.), DynaMill
(TM) Systems Limited (incorporated in the Province of British Columbia in
1996), DynaMotive Puerto Rico, Inc. (incorporated in Puerto Rico in 1997),
DynaPower, Inc. (incorporated in the Province of British Columbia in May 2000
under the name 606620 B.C. Ltd which was officially changed to DynaPower Inc.
in July 2000) and DynaMotive Canada, Inc. (federally incorporated in November
2000).  In this Report, unless the context otherwise requires, the terms the
"Company" and "DynaMotive" shall refer to DynaMotive Technologies Corporation.
The Company is currently listed on the over-the-counter bulletin board market
(OTCBB). Symbol: DYMTF.OB.


DESCRIPTION OF BUSINESS

     DynaMotive's primary focus is to commercialize its BioOil production
technology and establish this technology as the worldwide industry standard
for production of BioOil clean fuels. To support this goal we plan over the
next two years to expand upon our existing operations in Europe, the US, and
Canada as well as to develop commercial presence in Asia and Latin America.

     The Company has previously developed and commercialized two other
innovative industrial technologies which have produced commercial sales:
DynaPower(R), an acid free industrial metal cleaning system for wire
manufacturing with sales to date in twelve countries, and motion control
actuator systems used for robotic automotive manufacturing. In September 1997,
the Company sold certain rights to one of its actuator product lines to its
co-development partner, Emhart Tucker (a Black & Decker subsidiary).

     As of March 31, 2001, DynaMotive and its wholly owned subsidiaries have
active inventions protected by patents issued and patents pending via
in-house development or license, with the earliest U.S. patent scheduled to
expire on December 3, 2010.

     This Quarterly Report on Form 10-Q may contain forward looking statements,
within the meaning of the United States Securities Act of 1933, as amended,
and the United States Securities Exchange Act of 1934, as amended, regarding
DynaMotive Technologies Corporation. Actual events or results may differ
materially from the company's expectations, which are subject to a number of
known and unknown risks and uncertainties including but not limited to changes
and/or delays in product development plans and schedules, customer acceptance
of new products, changes in pricing or other actions by competitors, the
ability to integrate acuqition of Border Biofuel Ltd., and general economic
and market conditions. Other risk factors discussed in the Company's past
filings with the United States Securities and Exchange Commission may also
affect the actual results achieved by the Company

     The following discussion and analysis should be read in conjunction with
the financial statements and notes thereto included elsewhere herein. The
Company's quarterly operating results have been and will continue to be
affected by a wide variety of factors that could materially and adversely
affect revenues and profitability. These include factors relating to
competition, such as competitive pricing pressure and the potential
introduction of new products by competitors; manufacturing factors, including
constraints in the Company's supply of products from outside manufacturing and
assembly operations and shortages or increases in the prices of raw materials
and components; sales and distribution factors, such as changes in customer
base or distribution channels resulting in lower margins or the loss of a
significant alliance partner; new product development and introduction
problems, such as increased research, development, marketing and beta test
expenses associated with new product introductions, and delays in the
introduction of new products and technologies; as well as other factors,
including levels of expenses relative to revenue levels, personnel changes,
expenses that may be incurred in litigation, and fluctuations in foreign
currency exchange rates. The Company has experienced and expects to continue
to experience fluctuations in operating results, and there can be no assurance
 that the Company will achieve profitability in the future.


CORE TECHNOLOGIES & STRATEGIC BUSINESS UNITS

     The Company is organized into two strategic business units. The BioOil
Business Unit is commercializing a unique biomass-to-energy technology that
converts low value forest and agricultural wastes into liquid BioOil that can
be used as a "green" fuel for power generation or as the raw material for a
range of derivative products. The DynaPower Business Unit develops and markets
industrial metal wire cleaning systems that provide exceptional levels of
product cleanliness while eliminating the need for toxic chemical cleaning
systems traditionally used by the wire industry. In 2000, the Company
established the DynaPower division as a wholly owned operating subsidiary
named DynaPower, Inc.

BIOOIL BUSINESS UNIT

     The BioOil Business Unit develops and markets technology for the
production of biofuels (liquid: BioOil, solid: char and gaseous: non-
condensable gases). - rRenewable and non-depleting "green" fuels made from
biomass that can be used for generating heat and power in industrial boilers,
gas turbines and stationary diesel engines, as well as range of derivative
products including, blended fuels for transportation, slow release fertilizers
and specialty chemicals.

     By virtue of being derived from biomass waste, all BioOil fuels are
considered to be carbon dioxide ("CO2") and greenhouse gas neutral. When
combusted, they produce virtually no sulfur dioxide ("SOX") and significantly
reduced nitrogen oxide ("NOX") emissions, therefore having significant
advantages over fossil fuels with respect to reduction of atmospheric
pollution.

     DynaMotive has developed technical expertise internally to enable it to
design and build commercial-sized BioOil production plants in key markets
identified by the Company. The technology group will also provide technical
support and expertise to DynaMotive's operating companies around the world
while continuing to further develop the Company's BioOil technology and
applications.

BIOOIL PRODUCTION PROCESS

     BioOil is produced using a patented fast pyrolysis process, developed by
Resource Transforms International, Ltd. (RTI), trade named BioTherm(TM).
The process converts forest and agricultural waste, such as sawdust, sugar cane
bagasse and wheat straw amongst others, into commercial fuels (BioOil, char
and non-condensable gases).

     In the BioTherm(TM) reactor, biomass waste materials are rapidly heated in
the absence of oxygen. The rapidly vaporized volatiles are then quickly
condensed, forming a liquid fuel referred to as BioOil, solid char and non-
condensable gases. Depending upon the feedstock used (many different sources of
feedstock have been bench tested thus far), the process typically produces
60-75 tons of BioOil, 15-25 tons of char and approximately 15 tons of non-
condensable gases from 100 tons of biomass waste. The Company believes that the
overall simplicity of the BioTherm(TM) process and the fact that all the major
equipment is already well proven in existing related industrial applications
gives the Company's BioOil technology competitive advantages over other
pyrolysis conversion technologies such as lower capital and operating costs,
higher product yield, a significantly higher quality BioOil and the flexibility
to process a wide variety of feedstocks.

     The Company began producing batch quantities of BioOil in 1997 in its
0.5 tonne per day BioTherm(TM) pilot plant located at the Company's research
and development facility in Vancouver BC. By the end of 1998, the BioOil
Technology Group had upgraded, commissioned and operated the plant to a
capacity of two tonnes per day on a continuous basis. In 1999, further
changes were made to the feed system, BioTherm(TM) reactor, cyclone, and
instrumentation and control systems to provide increased stable operation. Once
these changes were made, the BioTherm(TM) was re-commissioned and produced
BioOil of sufficiently high quality to meet fuel specification requirements as
defined by our engine testing partners.

     The plant conforms to all applicable British Columbia safety, electrical
and mechanical design standards, utilizing state-of-the-art 'smart'
instrumentation and a high-powered industrial-grade distributed control system
(DCS). The Company adopted this design philosophy in order to facilitate easy
scale-up to commercial plant capacities. Once commissioned, the fully automated
plant will have a production capacity of 6,000 litres of BioOil per day,
providing much larger quantities of BioOil for engine and combustion test
programs. Depending on the development of derivative products described below,
the management may consider placing the plant into industrial service for
specialty applications in the future.

     Following the success of the new 10 tpd BioOil plant, the Company plans to
begin construction of a 50-70 tpd commercial demonstration plant in 2001 in the
UK which is intended to serve as a springboard for design and construction of
full scale, 100 to 400 tpd commercial plants to be built in Canada, Europe,
Brazil, Asia and other international markets

BIOOIL COMMERCIAL APPLICATIONS & MARKETS
     The nearest term and most appropriate commercial application for BioOil is
as a clean burning fuel to replace fossil fuels for generating power and heat
in industrial boilers, gas turbines and stationary diesel engines used in the
forest and sugar industries. In late 1998, the Company began shipping BioOil
from the pilot plant to various engine manufacturers and users for testing
purposes.

     The Company's initial target market for BioOil fuel is in Europe where,
given current fossil fuel price projections, BioOil fuel for power generation
could prove to be competitive. Strong regulatory pressures coupled with high
SOX, NOX and CO2 taxes on fossil fuels, renewable energy tax incentives and
subsidies make BioOil an attractive renewable energy option. Increasingly,
regulatory pressure and incentives are also creating opportunities in North
America that are being evaluated by the Company.

     There are also significant opportunities for the application of BioOil as
a fuel for power generation in countries that are heavily reliant on fossil
fuel imports and have a strong agricultural base producing large volumes of
biomass wastes. BioOil produced from these wastes could be used to replace
fossil fuels, while utilizing an abundant local resource. This is particularly
applicable to island economies (Caribbean/South Pacific) and to certain regions
in Latin America, the Far East, Australia and Africa.


FUTURE BIOOIL APPLICATIONS & DERIVATIVE PRODUCTS

     BioOil has a wide range of potential commercial applications. As the
BioOil industry matures it has the potential to follow a similar development
path as the petroleum industry beginning with exploitation of basic unrefined
BioOil fuels for power generation and district heating followed by blends and
emulsions for transportation. Development of higher value products including
agro-products, resins, adhesives, specialty chemicals, slow release fertilizers
and other derivatives may occur as refining and processing techniques are
established. Over time, we anticipate that BioOil will be refined in much the
same way that petroleum is today to derive the highest value energy and
chemical products.

CHAR PRODUCTION
     Char is a significant co-product of the Company's pyrolysis process. Char
is a granular solid with properties similar to coal. At 23 - 25 GJ per tonne,
pyrolysis char has a higher heating value than wood and many grades of coal.
Like BioOil, it is a "green" fuel which is CO2 neutral and does not contain any
sulfur.

     Early stage applications of char will focus on direct substitution or
augmentation of fossil fuels to produce process heat and power via commercially
available technologies in BioOil plants, sawmills, thermal power generation
and cement production. Char may also have potential for use as a feedstock for
manufacturing of charcoal briquettes.


BIOOIL STRATEGIC PARTNERS, INVESTMENT  AND GOVERNMENT FUNDING

     DynaMotive is commercializing its BioOil production technology through a
network of industrial and institutional partners. DynaMotive has formed
relationships with the following companies: Resource Transforms
International (RTI), Ltd. (original developer of the patented BioTherm(TM)
pyrolysis technology), Orenda Aerospace (a member of the Magellan Aerospace
Corporation and a recognized leader in power and propulsion technologies),
osan Bom Jesus (one of Brazil's and the world's largest sugar and ethanol
producers and exporters), Solar Turbines (a wholly owned subsidiary of
Caterpillar Inc. and the world leader in industrial turbines in the 1-15
megawatt capacity) and China Energy Holdings Limited (a wholly owned subsidiary
of China Strategic Holdings Limited of Hong Kong). An alliance with Canadian
Forest Products Ltd. (Canfor Corporation) was announced in March 2001.

     The Company's BioOil technologies are consistent with the environmental
and economic objectives of governments around the world. The Company has
received strong support from the Canadian federal government and is in
discussion with other governments and international agencies in target
markets directly and through project partners to examine BioOil financing and
grant potential. Canadian government support has been received from Industry
Canada/Technology Partnerships Canada (TPC) which has agreed to contribute
Cdn $8.2 million (US $6.1 million) to DynaMotive for development and
commercialization of BioOil fuels and derivative products and Natural Resources
Canada (NRCan) which has contributed $250,000 to support ongoing research and
development of BioOil at the CANMET national laboratory.


DYNAPOWER(R) ACID-FREE METAL CLEANING SYSTEMS

     The Company's DynaPower(R) technology cleans ferrous and non-ferrous
metals in a cost-effective manner without acids, caustics or solvents
traditionally used by the steel and wire industry, thus eliminating the risks
and costs associated with handling harmful chemicals and disposing of
hazardous waste. The metal wire cleaning system uses bipolar electrolysis and
ultrasound (DynaSonics(R)) to peel away scale, remove lubricants and create a
metal surface that is exceptionally clean, dry, PH-neutral and rust-resistant.
The DynaPower(R) Business Unit focuses on the following product applications:
stainless steel, mid and high carbon steel, extrusion clad steel, copper and
aluminum wire products.

     DynaPower(R) technology also allows the customer to use the process to
prepare metal surfaces ready for standard industry metal treatments
such as electroplating, hot-dip zinc coating and rubber adhesion. The
Company's wire cleaning equipment can continuously process wire at a rate
comparable to or better than conventional chemical cleaning processes but
without the added expenses and hazards otherwise encountered when using acid,
caustics or solvents.

      As part of a corporate reorganization in 1999, the Company decided to
outsource the manufacture of DynaPower(R) wire cleaning systems, thus reducing
staff and operational costs. In the year 2000, the Company has established
preferred supplier agreements with multiple vendors to further secure
manufacturing inputs and control costs.

     During the first quarter of 2001, DynaPower continues to work on
completing previous orders from customers In addition, during the first
quarter of 2001, DynaPower secured an additional order from Sumiden Wire
Products Corporation of Dickson, TN.  Sumiden Wire Products is a wholly
owned subsidiary of Sumitomo Electric Industries, Ltd., Japan (the forth
largest producer of wire and cable products in the world.)

     During the first quarter fo 2001, the Company has also completed the first
prototype of the DynaSonics(R) cleaning technology that it believes has
significant commercial potential for ultrasonic cleaning of wire drawing dies.
The Company has developed a novel process for cleaning diamond or tungsten
carbide dies which are used by the wire industry for drawing a variety of metal
wires. Die makers and wire mills have been aggressively looking for an
effective cleaning process to replace old, ineffective and slow processes.
DynaMotive believes that its new technology can be used by die makers to
quickly and effectively clean their dies during the manufacturing or servicing
 processes and by wire mills to clean their dies during regular maintenance.
The Company anticipates it will begin in-plant trials shortly.

     On May 1,2001 DynaMotive announced that it intends to divest its Metal
Cleaning Subsidiary, DynaPower, Inc. (DynaPower). Furthermore, it announced
that it has entered into a Letter of Intent with DynaPower Management for a
potential Management Buyout (MBO). The Company intends to retain intellectual
property ownership (Patents) and intends to receive on-going royalties from its
patents. While the Company intends to complete the divestiture by the third
quarter of this year, there can be no assurance that the divestituture will be
complete by the end of third quarter of 20001 or at all.


RESULTS OF OPERATIONS

     The company's financial statements have been prepared in accordance with
accounting principles generally accepted in Canada.  A reconciliation of
amounts presented in accordance with United States accounting principles is
detailed in note 11 of the company's consolidated financial statements.
Financial information concerning the Company's industry segments is summarized
in Note 10 to Consolidated Financial Statements.

     Total sales revenues for the first quarter of 2001 decreased to $97,118
while the same quarter for 2000 generated $266,942.  Revenue for the first
quarter of 2001 was lower than the same quarter in 2000 due to decline in
commercial sales volume of its DynaPower(R) metal cleaning systems. The
Company has announced its intent to divest its DynaPower business division to
focus on the commercial development of its BioOil technologies.

     Cost of sales in the first quarter of 2001 decreased to $75,780, from
$133,208 in the same period of 2000 due to corresponding decrease in sales of
DynaPower(R) metal cleaning systems. For the 3 months ended March 31, 2001,
the gross margin was 22.0% compared to 50.1% in the same period of 2000. The
quarter-to-quarter decrease in gross margin is due to introductory prices
offered to clients for promotional purpose.

     For the quarters ended March 31, 2001 and 2000 the company expended
$116,244 and $245,719 respectively on research and development. The decrease in
research and development expenditure during the first quarter of 2001 was due
to the constrction of 10 tons per day pilot plant. Of these amounts,$41,250 and
$73,341 respectively were sponsored by government funding.

     General and administrative salaries and benefits decreased to $293,100 in
the first quarter of 2001 compared to $679,779 in the same period of 2000. The
decrease is due to a one overtime and employee bonus payout in the first
quarter of 2000.

     Overall capital expenditures, net of government grants and disposals for
developing and patenting the Company's technologies increased to $174,696 in
the first quarter from $55,188 in the same period in 2000.  The majority of
the increase is due to repairs and upgrades to the company's existing test
equipments.

     The Company's total assets decreased to $4,023,222 at the end March 31,
2001 from $4,469,120 at the end of the same period in 2000.  The decrease is
due to collection of accounts and government grants receivables to fund
operating expenditures.  Liability decreased to $751,915 in the first quarter
of 2001 from $898,374 in the same quarter in 2000 primarily due to decrease in
trade accounts payable and accrued liabilities.

     The loss for the first quarter of 2001 was $1,242,958 as compared to
$1,149,055 for the same period in 2000.  The increase in loss is primarily
due to an increase in professional fees, the majorities of which were paid with
the issuance of restricted common shares.

     Use of cash in operating activities for the first quarter of 2001
decreased significantly to $278,412 from $603,717 of the same quarter in 2000.
The decrease in use of cash was primarily due to (i) changes in working capital
consisted of accounts and government grant receivables, deferred revenue, and
accounts payables, and (ii) increase in non-cash expenses paid in common
shares.

     The end-of-period deficit increased from $18,934,784 at March 31, 2000 to
$20,177,742 at March 31, 2001.  Even though the loss for the first quarter of
2001 increased slightly as compared to the same period in 2000, the loss per
common share remained the same at four cents ($0.04), due to a corresponding
increase in the weighted average number of common shares outstanding.

LIQUIDITY AND CAPITAL RESOURCES

     In Feburary 2001, the company completed the closing of a private placement
having raised an additional $500,695 from sales of 417,246 shares of its
common stock and $17,579 from 43,946 shares of common stock options exercised
for cash. During the first quarter ended March 31, 2001, the company received a
government assistance commitment of $211,578, all of which is included in
government grants receivable at March 31, 2001 as noted on note 5 and 9 of the
consolidated financial statements.

     With the current cash on hand and anticipated divesting of its DynaPower
business division to focus on the commercial development of its BioOil
technologies, the Company anticipates that it will require additional financing
for its operation and commercialization of its BioTherm(R) technologies during
this year. The company is working closely with a global investment bank with
the intent to raise up to $15 million in equity financing during the second
quarter of 2001.  Given the market condition and other factors, there can be no
guarantee that the Company will be successful in securing additional financing.
If adequate funds are not available on acceptable terms when needed, the
Company may be required to delay, scale-back or eliminate the manufacturing,
marketing or sales of one or more of its products or research and development
programs.


     As of the end of the first quarter of 2001, the Company had cash and cash
equivalents of $1,092,792, a decrease of $2,923 from the $1,095,715 as at
December 31, 2000. The primary sources for liquidity for the Company during the
first quarter of 2001 were from the Company's private placement offering
totaling $500,695 and collection of government grant receivables.  At the end
of the same quarter in 2000, the Company had cash and cash equivalents of
$3,993,706. Primary sources of liquidity for the first quarter of 2000 were
from the Company's private placements.

     During the first quarter of 2001, the Company generated cash in the amount
of $506,737 from financing activities, and used cash in operating and in
investing activities in the amounts of $278,412, and $174,696, respectively.
For the same quarter in 2000, the Company used cash in operating and in
investing activities in the amounts of $603,716 and $55,188, respectively,
while financing activities generated cash of $4,441,156.

     Cash used in operating activities for the first quarter of 2001, which
consists of a loss for the period of $1,242,958, was partially offset by
amortization, and stock based compensation expense in the amount of $87,444,
and $481,594, respectively. Non-cash working capital items increased by
$395,508 during the first quarter of 2001. Cash used in operating activities
for the same quarter in 2000 consisted of a loss of $1,149,055, which was
partially offset by amortization and non-cash compensation expenses in the
amount of $67,638, and $283,668 respectively. Non-cash working capital items
increased by $194,033 during the same quarter in 2000.

     Financing activities for the first quarter of 2001 included a private
placement offering and common stock options exercise for cash totaling
$518,274.  Financing activities for the first quarter of 2001 also included
a decrease of $11,537 in bank indebtedness.

     Investing activities resulted in a net decrease of cash by $174,696 for
the first quarter of 2001 which consisted of $181,699, net of government
grants, incurred in acquisitions and upgrades of capital assets,  an increase
of $7,002 as a result of revaluation of patent costs.


RECENT DEVELOPMENTS AND FUTURE EVENTS

     In January, 2001 the Company began commissioning of its new 10 tonne per
day BioOil plant, construction of which was completed on budget and in record
time in December 2000. The initial production runs were completed successfully
and fuel quality BioOil was produced from wood waste. With a processing
capacity of 10 tonnes of biomass feedstock per day, the fully automated plant
has been built to industrial standards in order to facilitate scale-up of the
technology to full scale commercial capacity. Delivering to the marketplace a
technology that is reliable, replicable and scalable is a cornerstone of the
Company's development strategy. Completion of the new plant brings the Company
one step closer to development of full scale commercial BioOil facilities.

     During first quarter of 2001, the Company announced that it had
successfully completed BioOil combustion testing at Natural Resources
Canada's (NRCan) CANMET Energy Technology Centre (CETC) in Ottawa, Ontario.
The success of this test program creates opportunities for early commercial
applications for BioOil as a clean burning fuel to replace natural gas, diesel
and other fossil fuels in the multi-billion dollar industrial fuels market.
Customers for BioOil fuels could potentially include local, regional and
international energy users such as electrical utilities, forest companies, oil
and gas producers and manufacturing companies.

     Also during the first quarter, the Company announced that it has signed a
Memorandum of Understanding (MOU) with TECNA S.A. of Argentina, a major
engineering and construction company that has played a leading role in the
oil and gas sector in Latin America and internationally. Under terms of the
MOU, TECNA would provide engineering, procurement and construction (EPC)
services for commercial BioOil energy projects in Latin America and other
markets on a non-exclusive basis. TECNA would also collaborate with DynaMotive
to provide technical design and input optimization on DynaMotive's BioOil
production technology. The agreement with TECNA is another critical step in
the Company's commercialization strategy by which it will gain proven
capabilities in project development and construction. These are expected to
translate into efficiencies in engineering design, procurement, construction
and project management.

     On March 8, 2001 the Company officially opened its new BioOil plant
and announced a Memorandum of Understanding alliance with Canadian Forest
Products Ltd., Canada's largest forest products company,
to develop commercial BioOil applications in the forest industry. This
partnership is a significant milestone in DynaMotive's commercialization
program. The MOU establishes a framework for collaboration through several
stages of development. Initially, Canfor will provide prepared feedstock for
the operation of DynaMotive's 10 tonne per day pilot plant and work with
DynaMotive to validate BioOil fuel applications in sawmills and pulp mills.
The companies have also established the principles for developing a 25 - 50
tonne per day BioOil demonstration project and for commercial BioOil projects
including feedstock supply and fuel purchase agreements.

     During the first quarter 2001, representatives of the Company attended
a number of important renewable energy and environmental conferences and trade
fairs including: EECO (Environment and Energy Conference) in Toronto Ontario in
January where Chief Operating Officer made a presentation; Environment 2001 in
Abu Dhabi, U.A.E.;  2nd World Sugar Conference in Miami, Florida where Chief
Technology Officer Keith Morris presented a technical paper; and the Green
House Gas Forum in New York where Director of Research and Development Dr. Jan
Barynin, Ph.D. presented a technical paper.

     In April 2000, the Company acquired 75% of Border Biofuels Limited (BBL),
a UK Green Power project development company. Through the acquisition of BBL,
the Company has accessed 15 year power purchase contracts in the UK for the
production of 60 MW of electricity. Projects are to be fuelled by BioOil. The
contracts provide an option for, but not the obligation to provide power.

     On May 1,2001 DynaMotive announced that it intends to divest its Metal
Cleaning Subsidiary, DynaPower, Inc. (DynaPower). Furthermore, it announced
that it has entered into a Letter of Intent with DynaPower Management for a
potential Management Buyout. The Company intends to retain intellectual
property ownership (Patents) and intends to receive on-going royalties from its
patents. While the Company intends to complete the divestiture by the third
quarter of this year, there can be no assurance that the divestituture will be
complete by the end of third quarter of 20001 or at all.


ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     The Company is affected by fluctuations in foreign currencies and changes
in interest rates. The Company's revenue is primarily in US dollars while the
majority of its expenses are in Canadian currency. The Company holds cash in
both US and Canadian funds and exchanges from US currency to Canadian currency
as necessary.

     The Company can be adversely affected when the Canadian currency
appreciates. The management has the ability, to some extent, to time exchanges
 and enter into forward exchange contracts in an attempt to mitigate such risk.
The company reports in US currencies. When translating the Company's financial
statements from Canadian dollars to US currencies, depending on the prevailing
exchange rate at the time, certain impact from prior exchange transactions may
be off-set. The extent of the Company's exposure depends on the degree of
fluctuation in foreign currencies. Due to the nature of foreign currency
exchange, the exact exposure is difficult to estimate.

     The Company holds its cash reserve in short term deposits. The interest
revenue obtained from these instruments will depend on the market interest
rates prevailing at the time. Based on cash positions at March 31, 2001, the
change in interest revenue due to changes in market interest rates is not
material. The Company also has short term credit facilities which it draws upon
and repays as necessary. The interest expense depends on the prevailing market
rate at the time. Due to the average size of the loan outstanding at any one
time, the differences in interest expenses resulting from fluctuation in
interest rates are not material.

PART II    OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS
To be discussed with Bernie - May not be material, therefore may be eliminated

     During the third quarter 2000, the Company was named a party to a legal
proceeding filed by HPG Research Ltd., a British Columbia company, in the
Supreme Court of British Columbia, for an alleged breach of a Royalty
Agreement, executed between the Company and HPG in 1993, and potential claim
of a certain percentage of DynaPower sales. As at the end of 2000, the parties
agreed to proceed to arbitration under the Commercial Arbitration Act of
British Columbia and are in the process of finding a suitable arbitrator for
this matter. No arbitrator has been appointed as at the end of first quarter
2001.

      At the end of the first quarter 2001, the Company was named a party to a
legal proceeding filed by Southwestern Wire, Inc. (SWI), an Oklahoma
corporation, in the District Court of Cleveland County, State of Oklahoma for
an alleged breach of contract by the Company with respect to SWI's purchase of
a 24 wire DynaPower cleaning system for a potential claim of $101,000.

ITEM 2.     CHANGES IN SECURITIES AND USE OF PROCEEDS

     In February 2001, the Company closed a private placement financing of its
common shares, no par value, for a total of $500,695 at a share price of $1.20
per share. Subscribers to the funding also received a warrant to purchase one-
fifth of a share of common stock for each share of common stock purchased. The
warrants have a two year term, subject to accelerated termination under
certain circumstances and are exercisable at a share price equal to $2.00.
A total of 417,246 shares and 83,448 warrants were issued to: BC Advanced
Systems Foundation, K.F. McCready, and hia Tai Chen.

     The offering was made, and the securities were sold to purchasers who
are not U.S. Persons (as defined in Regulation S prmogated under the US
Securties Act) and is therefore exempt  from United States registration
requirements under Regulation S. The securities issued have not been
registered under the Securities Act of 1933 and may not be offered or sold
in the United States absent registration or an applicable exemption from
registration.




ITEM 6. EXHIBITS and REPORTS ON FORM 8-K


   (a) Exhibits

       3.1 Company Act Memorandum of DynaMotive Technologies Corporation, as
           amended to date (filed as Exhibit 3.1 to the Company's Quarterly
           Report on Form 10-QSB for the quarter ended June 30, 2000.)

       3.2 Articles of DynaMotive Technologies Corporation, as amended to date
           (filed as Exhibit 3.2 to the Company's Quarterly Report on Form
           10-QSB for the quarter ended June 30, 2000.)



   (b) Reports on Form 8-K

       None.

                           DYNAMOTIVE TECHNOLOGIES CORPORATION

                                       SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized as of the 15th day of May 2001.

                                   DYNAMOTIVE TECHNOLOGIES CORPORATION


                                   /s/ Robert Andrew Kingston
                                   ------------------------------------
                                   Robert Andrew Kingston,
                                   President & Chief Executive Officer

                                   /s/ Stephen Ives
                                   ------------------------------------
                                   Stephen Ives
                                   Chief Financial Officer




                                           Exhibit Index


Exhibit                     Description

3.1                         Company Act Memorandum of DynaMotive Technologies
                            Corporation, as amended to date (filed as Exhibit
                            3.1 to the Company's Quarterly Report on Form
                            10-QSB for the quarter ended June 30, 2001.)

3.2                         Articles of DynaMotive Technologies Corporation,
                            as amended to date (filed as Exhibit 3.2 to the
                            Company's Quarterly Report on Form 10-QSB for the
                            quarter ended June 30, 2000.)







37